ARCELLX Trademark

Trademark Overview

On Friday, January 7, 2022, a trademark application was filed for ARCELLX with the United States Patent and Trademark Office. The USPTO has given the ARCELLX trademark a serial number of 97208593. The federal status of this trademark filing is REGISTERED as of Tuesday, February 6, 2024. This trademark is owned by Arcellx, Inc.. The ARCELLX trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations for the treatment of cancer using genetically engineered cells; pharmaceutical preparations for targeting tissues based on select tissue markers and ligands for treating cancer; pharmaceutical preparations for the purpose of binding ligands using receptors for treating cancer; pharmaceutical preparations for immunotherapy using genetically engineered cells for treating cancer
arcellx

General Information

Serial Number97208593
Word MarkARCELLX
Filing DateFriday, January 7, 2022
Status700 - REGISTERED
Status DateTuesday, February 6, 2024
Registration Number7300306
Registration DateTuesday, February 6, 2024
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 7, 2023

Trademark Statements

Description of MarkThe mark consists of "ARCELLX" in navy blue in stylized form. To the left are two overlapping bars, one in purple and the other in a blue gradient that transitions to purple.
Goods and ServicesBiological preparations for the treatment of cancer using genetically engineered cells; pharmaceutical preparations for targeting tissues based on select tissue markers and ligands for treating cancer; pharmaceutical preparations for the purpose of binding ligands using receptors for treating cancer; pharmaceutical preparations for immunotherapy using genetically engineered cells for treating cancer
Indication of Colors claimedThe color(s) navy blue, purple, and blue is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 14, 2022
Primary Code005
First Use Anywhere DateFriday, January 31, 2020
First Use In Commerce DateThursday, April 30, 2020

Trademark Owner History

Party NameArcellx, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94065
Party NameArcellx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878
Party NameArcellx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878

Trademark Events

Event DateEvent Description
Tuesday, February 13, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 13, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 13, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 13, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 13, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 6, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 6, 2024REGISTERED-PRINCIPAL REGISTER
Thursday, January 4, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, January 3, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, December 7, 2023ASSIGNED TO EXAMINER
Tuesday, November 7, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, October 25, 2023USE AMENDMENT FILED
Tuesday, November 7, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, October 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 25, 2023TEAS STATEMENT OF USE RECEIVED
Wednesday, October 25, 2023SOU EXTENSION 1 GRANTED
Wednesday, October 25, 2023SOU EXTENSION 1 FILED
Wednesday, October 25, 2023SOU TEAS EXTENSION RECEIVED
Friday, July 7, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 7, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 7, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 2, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 7, 2023PUBLISHED FOR OPPOSITION
Wednesday, February 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 16, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, January 15, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, January 15, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 13, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 13, 2022NON-FINAL ACTION E-MAILED
Tuesday, September 13, 2022NON-FINAL ACTION WRITTEN
Wednesday, September 7, 2022ASSIGNED TO EXAMINER
Saturday, January 15, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, January 14, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 11, 2022NEW APPLICATION ENTERED

Related Keywords

arcellx preparations cancer pharmaceutical treating using cells ligands engineered genetically immunotherapy